NLRP3 and stroke disorder: In line with the latter, a recently published study supports that NLRP3 inhibition and knockout seem not to influence stroke sizes after tMCAO, indicating that the NLRP3 pathway does not contribute to the inflammation exacerbating ischemic brain damage [26].